Skip to main content

Discovering Novel Adverse Drug Events Using Natural Language Processing and Mining of the Electronic Health Record

  • Conference paper
Artificial Intelligence in Medicine (AIME 2009)

Part of the book series: Lecture Notes in Computer Science ((LNAI,volume 5651))

Included in the following conference series:

Abstract

This talk presents an overview of our research in use of medical knowledge, natural language processing, the electronic health record, and statistical methods to automatically discover novel adverse drug events, which are serious problems world-wide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Classen, D.C., Pestotnik, S.L., Evans, R.S., Lloyd, J.F., Burke, J.P.: Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277(4), 301–306 (1997)

    Article  CAS  PubMed  Google Scholar 

  2. Bates, D.W., Spell, N., Cullen, D.J., et al.: The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 277(4), 307–311 (1997)

    Article  CAS  PubMed  Google Scholar 

  3. Schneeweiss, S., Hasford, J., Gottler, M., Hoffmann, A., Riethling, A.K., Avorn, J.: Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur. J. Clin. Pharmacol. 58(4), 285–291 (2002)

    Article  PubMed  Google Scholar 

  4. Chiang, A.P., Butte, A.J.: Data-driven methods to discover molecular determinants of serious adverse drug events. Clin. Pharmacol. Ther. 85(3), 259–268 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Amery, W.K.: Why there is a need for pharmacovigilance. Pharmacoepidemiol Drug Saf. 8(1), 61–64 (1999)

    Article  CAS  PubMed  Google Scholar 

  6. Goldman, S., Kennedy, D., Graham, D., et al.: The clinical impact of adverse event reporting. Center for Drug Evaluation and Research. Food and Drug Administration (1996)

    Google Scholar 

  7. Moride, Y., Haramburu, F., Requejo, A.A., Begaud, B.: Under-reporting of adverse drug reactions in general practice. Br. J. Clin. Pharmacol. 43(2), 177–181 (1997)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wood, L., Martinez, C.: The general practice research database: role in pharmacovigilance. Drug Saf. 27(12), 871–881 (2004)

    Article  PubMed  Google Scholar 

  9. Berlowitz, D.R., Miller, D.R., Oliveria, S.A., Cunningham, F., Gomez-Caminero, A., Rothendler, J.A.: Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin. Pharmacoepidemiol. Drug Saf. 15(11), 799–807 (2006)

    Article  CAS  PubMed  Google Scholar 

  10. Friedman, C., Shagina, L., Lussier, Y., Hripcsak, G.: Automated encoding of clinical documents based on natural language processing. J. Am. Med. Inform. Assoc. 11(5), 392–402 (2004)

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lindberg, D., Humphreys, B., McCray, A.T.: The Unified Medical Language System. Meth. Inform. Med. 32, 281–291 (1993)

    CAS  PubMed  Google Scholar 

  12. Cao, H., Hripcsak, G., Markatou, M.: A statistical methodology for analyzing co-occurrence data from a large sample. J. Biomed. Inform. 40(3), 343–352 (2007)

    Article  PubMed  Google Scholar 

  13. Wang, X., Friedman, C., Chused, A., Markatou, M., Elhadad, N.: Automated knowledge acquisition from clinical narrative reports. AMIA Annu. Symp. Proc., 783–777 (2008)

    Google Scholar 

  14. Chen, E.S., Hripcsak, G., Xu, H., Markatou, M., Friedman, C.: Automated acquisition of disease-drug knowledge from biomedical and clinical documents: an initial study. J. Am. Med. Inf. Assoc. 15(1), 87–98 (2008)

    Article  Google Scholar 

  15. Wang, X., Hripcsak, G., Markatou, M., Friedman, C.: Active Computerized Pharmacovigilance using Natural Language Processing, Statistics, and Electronic Health Records: a Feasibility Study. J. Am. Med. Inform. Assoc. 16(3), 328–337 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wang, X., Hripcsak, G., Friedman, C.: Characterizing environmental and phenotypic associations using information theory and electronic health records. In: 2009 AMIA Summit, March 15, p. 134 (full paper selected for publication in BMC Bioinformatics) (2009)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Friedman, C. (2009). Discovering Novel Adverse Drug Events Using Natural Language Processing and Mining of the Electronic Health Record. In: Combi, C., Shahar, Y., Abu-Hanna, A. (eds) Artificial Intelligence in Medicine. AIME 2009. Lecture Notes in Computer Science(), vol 5651. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02976-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-02976-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-02975-2

  • Online ISBN: 978-3-642-02976-9

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics